In a murine breast cancer model, intratumoral reovirus increased PD-L1 expression on tumour cells, and combination reovirus/anti-PD-1 treatment improved survival by reducing Treg numbers and ameliorating tumour-specific cytotoxic T lymphocyte responses (48). The gene discussed is PDCD1; the disease is breast cancer.